- Home
- RPTX vs NXN Comparison
RPTX vs NXN Comparison
Compare RPTX & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- NXN
- Stock Information
- Founded
- RPTX 2016
- NXN 1992
- Country
- RPTX Canada
- NXN United States
- Employees
- RPTX N/A
- NXN N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- NXN Trusts Except Educational Religious and Charitable
- Sector
- RPTX Health Care
- NXN Finance
- Exchange
- RPTX Nasdaq
- NXN Nasdaq
- Market Cap
- RPTX 53.2M
- NXN 46.2M
- IPO Year
- RPTX 2020
- NXN N/A
- Fundamental
- Price
- RPTX $0.93
- NXN $11.36
- Analyst Decision
- RPTX Strong Buy
- NXN
- Analyst Count
- RPTX 3
- NXN 0
- Target Price
- RPTX $4.50
- NXN N/A
- AVG Volume (30 Days)
- RPTX 266.1K
- NXN 9.7K
- Earning Date
- RPTX 05-06-2025
- NXN 01-01-0001
- Dividend Yield
- RPTX N/A
- NXN 4.23%
- EPS Growth
- RPTX N/A
- NXN N/A
- EPS
- RPTX N/A
- NXN 0.24
- Revenue
- RPTX $53,477,000.00
- NXN N/A
- Revenue This Year
- RPTX N/A
- NXN N/A
- Revenue Next Year
- RPTX $2.61
- NXN N/A
- P/E Ratio
- RPTX N/A
- NXN $48.42
- Revenue Growth
- RPTX 4.58
- NXN N/A
- 52 Week Low
- RPTX $0.89
- NXN $10.64
- 52 Week High
- RPTX $4.29
- NXN $12.45
- Technical
- Relative Strength Index (RSI)
- RPTX 34.51
- NXN 32.24
- Support Level
- RPTX $0.89
- NXN $11.07
- Resistance Level
- RPTX $1.02
- NXN $11.69
- Average True Range (ATR)
- RPTX 0.07
- NXN 0.17
- MACD
- RPTX -0.01
- NXN -0.05
- Stochastic Oscillator
- RPTX 19.10
- NXN 41.28
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.